Obesity drugmaker Rivus is working with banks to complete a US public listing that could happen before the end of the year.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Another month, another frustratingly sticky inflation report. Still, a rate cut seems certain when the Federal Reserve meets next week.
With more break away advisors going independent than ever, the landscape is becoming trickier to navigate.
Amazon touts itself as the everything store, and now there’s one more market it’s absorbing into its everythingness.